Duration of Peripheral Nerve Blocks in Opioid Tolerant Individuals - A Volunteer Blinded Matched Case-control Study

Last updated: June 28, 2024
Sponsor: Charlotte Runge
Overall Status: Active - Recruiting

Phase

N/A

Condition

Anesthesia (Local)

Treatment

Radial nerve block

Clinical Study ID

NCT06488768
2023-509351-13-00
  • Ages 18-84
  • All Genders
  • Accepts Healthy Volunteers

Study Summary

Do peripheral nerve blocks work shorter if you are on opioids?

Background:

Peripheral nerve blocks effectively alleviate postoperative pain. Animal studies and human research indicate that opioid tolerance results in reduced effectiveness of local analgesics. This applies to both central nerve blockade and infiltration anaesthesia. The impact on peripheral nerve block in humans has not been evaluated. The aim of the study is to assess the onset time and duration of a radial nerve block in opioid tolerant individuals compared to opioid naive individuals. We hypothesise that peripheral nerve blocks cause shorter sensory and motor block in opioid-tolerant compared to opioid-naive counterparts.

Methods:

Twenty opioid-tolerant individuals will be matched by sex and age with opioid-naïve counterparts. Participants will undergo an ultrasound-guided radial nerve block. The onset time and duration of motor and sensory blockade will be tested and measured. The primary outcome is difference in duration of sensory nerve blockade between the two groups. The secondary outcomes include the onset time of sensory blockade, onset time of motor blockade, and difference in duration of motor nerve blockade.

Perspectives:

The data from this study will provide evidence for the duration of peripheral nerve block in opioid tolerant individuals and support if a specific postoperative protocol for opioid tolerant individuals is needed or it should be of special attention.

Eligibility Criteria

Inclusion

Inclusion criteria for opioid group

  • Age > 18 years old

  • ASA 1-3

  • Chronic pain, defined as persisting pain for more than three months

  • Daily use of more than 60 mg of morphine equivalent in more than 7 days

  • Legally competent and able to give informed consent

Inclusion criteria for the opioid naive control group

  • Age > 18 years old

  • ASA 1-3

  • No use of opioids within 30 days prior to participation

  • Legally competent and able to give informed consent

Exclusion

Exclusion Criteria:

  • Age > 84 years old

  • Volunteers who cannot cooperate with the study

  • Volunteers who cannot understand or speak Danish

  • Allergy to the lidocaine or the preservatives used in the study

  • Alcohol or drug abuse other than opioids

  • Peripheral neuropathy at the upper limb non-dominant arm

  • Pathology or previous major surgery to the upper limb

  • Active signs of infection in the cutaneous area of injection

  • Pregnancy at the time of the trial

  • Partial or complete 2nd or 3rd degree atrioventricular heart block without apacemaker

  • Severe liver disease

  • Severe kidney disease and reduced kidney function (eGFR below 30 mL/min)

  • Daily treatment with drugs that are structurally related to local analgesics orclass IB antiarrhythmics, as the toxic effects are additive

  • Daily treatment with class III antiarrhythmics e.g., amiodarone.

Study Design

Total Participants: 40
Treatment Group(s): 1
Primary Treatment: Radial nerve block
Phase:
Study Start date:
June 17, 2024
Estimated Completion Date:
May 01, 2025

Connect with a study center

  • Silkeborg Regional Hospital

    Silkeborg, 8600
    Denmark

    Active - Recruiting

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.